Disproportional inflation of clinical trial costs: why we should care, and what we should do about it.

Hijma HJ, Zhuparris A, van Hoogdalem EJ, Cohen AF

Clinical trial costs seem to be inflating excessively, without a clear increase in the value of the information gained. Here, we highlight factors that could be driving this trend and discuss potential solutions.